Caltech scientists develop way to visualize gene expression using MRI

Scientists from the California Institute of Technology (Caltech) have developed a method to visualize gene expression in cells using magnetic resonance imaging (MRI).

Their study, published Dec. 23 online in the journal Nature Communications, was led by Mikhail Shapiro, an assistant professor of chemical engineering at Caltech.

Shapiro and his team developed a method to link MRI signals to cells, including tumor cells. The technique could eventually be used in humans, and would be a non-invasive procedure.

"We thought that if we could link signals from water molecules to the expression of genes of interest, we could change the way the cell looks under MRI," said Arnab Mukherjee, a postdoctoral scholar in chemical engineering at Caltech and co-lead author on the study, in a statement.

The investigators tested their technique on aquaporin cells, a protein that naturally occurs in humans and sits within the membrane that envelops cells and acts as a gatekeeper for water molecules. Results showed that increasing the number of aquaporins on a cell made it appear clearer in MRI images when using a specific imaging strategy sensitive to the movement of water molecules. Using this imaging technique, the researchers found it was successful in monitoring gene expression in a brain tumor in mice.

"Overexpression of aquaporin has no negative impact on cells because it is exclusive to water and simply allows the molecules to go back and forth across the cell membrane," Shapiro said. “Aquaporin is a very convenient way to genetically change the way that cells look under MRI."

And because aquaporin is safe for humans, it could be used to examine gene expression.

"An effective reporter gene for MRI is a 'holy grail' in biomedical imaging because it would allow cellular function to be observed non-invasively," Shapiro said "Aquaporins are a new way to think about this problem. It is remarkable that simply allowing water molecules to more easily get into and out of cells in a tissue gives us the ability to remotely see those cells in the middle of the body."

 

Katherine Davis,

Senior Writer

As a Senior Writer for TriMed Media Group, Katherine primarily focuses on producing news stories, Q&As and features for Cardiovascular Business. She reports on several facets of the cardiology industry, including emerging technology, new clinical trials and findings, and quality initiatives among providers. She is based out of TriMed's Chicago office and holds a bachelor's degree in journalism from Columbia College Chicago. Her work has appeared in Modern Healthcare, Crain's Chicago Business and The Detroit News. She joined TriMed in 2016.

Around the web

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

The all-in-one Omni Legend PET/CT scanner is now being manufactured in a new production facility in Waukesha, Wisconsin.

Trimed Popup
Trimed Popup